project id: TCGA-OV; case submitter id: TCGA-13-2065; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.3; rna integrity number: 5.5; spectrophotometer method: UV Spec; age at index: 71; days to birth: -25973; ethnicity: not reported; gender: female; race: black or african american; vital status: Alive; year of birth: 1938; age at diagnosis: 25973; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1993.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.5; longest dimension: 2.0; preservation method: Unknown; shortest dimension: 0.6; sample id: 82a783d9-ca3a-4d3f-8524-8c74eabd525a; sample submitter id: TCGA-13-2065-01A; portion id: 2f924030-e9a5-48fe-9a3a-43f836049bb7; portion submitter id: TCGA-13-2065-01A-01; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0;